The Committee for medicinal products for Human Use (CHMP) has recommended the approval of the erectile dysfunction treatment, Cialis 5mg once a day, for the treating of benign prostatic hyperplasia (BPH). The Food and Drug Administration (FDA) in the States has already approved the drug for treating those who experience the symptoms of this condition.
Those who take nitrates, which are typically used in the treating of chest pain and also used in poppers, will be contraindicated for Cialis as the combination of the drug and nitrates are said to cause the level of blood pressure to drop dramatically.
The CHMP announced its recommendation after data concerning safety and efficacy from 1,500 patients, over 4 clinical studies, had been reviewed.